Prevalence of visual impairment in the adult Japanese population by cause and severity and future projections

Ophthalmic Epidemiology

Volumn 17, Issue 1, 2010, Pages 50-57

  Yamada, Masakazu ^a   Hiratsuka, Yoshimune ^b   Roberts, Chris B ^c   Pezzullo, M Lynne ^c   Yates, Katie ^c   Takano, Shigeru ^d   Miyake, Kensaku ^e   Taylor, Hugh R ^f  

^a NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Access Economics Pty Limited   (Australia)

^d Takano Eye Clinic   (Japan)

^e Miyake Eye Hospital   (Japan)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Burden of disease; Epidemiology; Eye disease; Prevalence; Visual impairment

Indexed keywords

ADULT; AGED; ARTICLE; BLINDNESS; CATARACT; CONTROLLED STUDY; DEGENERATIVE MYOPIA; DIABETIC RETINOPATHY; DISEASE SEVERITY; FEMALE; GLAUCOMA; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; VISUAL DISORDER; VISUAL IMPAIRMENT; AGE DISTRIBUTION; ASIAN; ETHNOLOGY; EYE DISEASE; FORECASTING; HOSPITALIZATION; JAPAN; MIDDLE AGED; PATIENT; SEX RATIO; STATISTICS; VISUAL ACUITY;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BLINDNESS; EYE DISEASES; FEMALE; FORECASTING; HUMANS; JAPAN; MALE; MIDDLE AGED; PREVALENCE; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; VISUAL ACUITY; VISUALLY IMPAIRED PERSONS;

EID: 75749088592     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.3109/09286580903450346     Document Type: Article

References (33)

1. Tielsch JM, Sommer A, Witt K, et al. Blindness and visual impairment in an American urban population. The Baltimore Eye Survey. Arch Ophthalmol 1990;108:286-290.
2. Klein R, Klein BEK, Linton KLP, et al. The Beaver Dam Eye Study: Visual acuity. Ophthalmology 1991;98:1310-1315.
3. Taylor HR, Livingston PM, Stanislavsky YL, et al. Visual impairment in Australia: distance visual acuity, near vision, and visual field findings of the Melbourne Visual Impairment Project. Am J Ophthalmol 123;328-337:1997.
4. Klaver CC, Wolfs RC, Vingerling JR, et al. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 116;653-658:1998.
5. Foran S, Wang JJ, Mitchell P. Causes of visual impairment in two older population cross-sections: The Blue Mountains Eye Study. Ophthamic Epidemiol 2003;10:215-225. (Pubitemid 37041277)
6. Congdon N, O'Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004;122:477-485. (Pubitemid 38456282)
7. Wong TY, Loon S-C, Saw, S-M.. The epidemiology of age related eye diseases in Asia. Br J Ophthalmol 2006;90:506-511.
8. Li Z, Cui H, Liu P, et al. Prevalence and causes of blindness and visual impairment among the elderly in rural southern Harbin, China. Ophthalmic Epidemiol 15;334-338:2008.
9. National Institute of Population and Social Security Research, Ministry of Health, Labour and Welfare. http:// www.ipss.go.jp
10. Iwano M, Nomura H, Ando F, et al. Visual acuity in a community-dwelling Japanese population and factors associated with visual impairment. Jpn J Ophthalmol 2003;48:37-43.
11. Iwase A, Araie M, Tomidokoro A, et al. Prevalence and causes of low vision and blindness in a Japanese adult population: The Tajimi Study. Ophthalmology 2006;113:1354-1362.
12. Yamamoto T, Iwase A, Araie M, et al. The Tajimi Study Report 2: Prevalence of primary angle closure and secondary glaucoma in a Japanese population. Ophthalmology 2005;112:1661-1669.
13. Miyazaki M, Kubo M, Kiyohara Y, et al. Comparisons of diagnostic methods for diabetes mellitus based on prevalence of retinopathy in a Japanese population: the Hisayama study. Diabetologia 2004;47:1411-1415.
14. Japanese Clinical Medicine Association Study Group. The Study on Diabetic Neuropathy Report 3. Retinopathy, nephropathy, complications. Nippon Rinsho Naika Ikai Zasshi. (in Japanese) 2001;16:383-402.
15. Miyazaki M, Kiyohara Y, Yoshida A, et al. The 5-year incidence and risk factors for age-related maculopathy in a general Japanese population: the Hisayama study, Invest Ophthalmol Vis Sci 2005;46:1907-1910.
16. Oshima Y, Ishibashi T, Murata T, et al. Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study. Br J Ophthalmol 2001; 85: 1153-1157.
17. Yuzawa M, Tamakoshi A, Kawamura T, et al. Report on the nationwide epidemiological survey of exudative agerelated macular degeneration in Japan. Int Ophthalmol 1997;21:1-3.
18. Sasaki K, Kojima M. Population based cataract epidemiological surveys utilizing a photodocumentation system. Doc Ophthalmol 1995;88:277-283.
19. Sasaki K, Ono M, Aoki K, et al. Cataract epidemiology survey in the three climatically different areas in Japan. Prevalence of cataracts and types of lens opacification. Nippon Ganka Gakkai Zasshi. (in Japanese) 1995;99:204-211
20. Shimizu, N, Nomura, H, Ando, F, et al. Refractive errors and factors associated with myopia in an adult Japanese population. Jpn J Ophthalmol. 2003;47:6-12.
21. Matsumura H. Hirai H. Prevalence of myopia and refractive changes in students from 3 to 17 years of age. Surv Ophthalmol 1999;44:S109-S115.
22. Nakae K, Masuda K, Senoo T, et al. Aging society and eye disease, a recent epidemiological study on underlying diseases responsible for visual impairment, Geriat Med (in Japanese) 2006;44:1221-1224.
23. National Committee of Welfare for the Blind in Japan, Ministry of Health, Labour and Welfare. Persons with visual impairment in Japan: the 2004 Edition. Tokyo, Japan; 2006.
24. The Statistics Bureau and the Director-General for Policy Planning (Statistical Standards), Ministry of Internal Affairs and Communications. http://www.stat.go.jp/english/ data/index.htm
25. Klein BE, Klein R, Linton KL. Prevalence of age-related lens opacities in a population. The Beaver Dam Eye Study. Ophthalmology 1992;99:546-552.
26. Klein R, Klein BE, Linton KL, et al. The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am J Epidemiol 1993;137:190-200. (Pubitemid 23083671)
27. Christen WG, Glynn RJ, Manson JE, et al. A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA. 1996;276:1147-1151.
28. Sho K, Takahashi K, Yamada H, et al. Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. Arch Ophthalmol 2003;121: 1392-1396.
29. Uyama M, Matsubara T, Fukushima I, et al. Idiopathic polypoidal choroidal vasculopathy in Japanese patients. Arch Ophthalmol 1999;117:1035-1042.
30. Taylor HR, Pezzullo ML, Keeffe JE. The economic impact and cost of visual impairment in Australia. Br J Ophthalmol 2006;90:272-275.
31. Taylor HR, Pezzullo ML, Nesbitt SJ, et al. Costs of interventions for visual impairment. Am J Ophthalmol 2007;143:561-565.
32. Chia E-M, Wang JJ, Rochychina E, et al. Impact of bilateral visual impairment on health-related quality of life: the Blue Mountain eye study. Invest Ophthalmol Vis Sci 2004;45: 71-76.
33. Varma R, Wu J, Chong K, et al. Impact of severity and bilaterality of visual impairment on health-related quality of life. Ophthalmology 2006;113:1846-1853.